Skip Nav Destination
Frontiers of Radiation Therapy and Oncology
Controversies in Uro-Oncology: 5th International Symposium on Special Aspects of Radiotherapy, Berlin, May 2000Available to Purchase
S.Karger AG
Volume
36
Status:
Available
ISBN electronic:
978-3-318-00695-7
ISBN print:
978-3-8055-7217-0
Book Series:
Frontiers of Radiation Therapy and Oncology
Publication date:
2002
Book Details
Over the past few years, tremendous progress has been made in the development of therapies for prostate and bladder cancer. As a consequence, greatly improved surgical techniques as well as new forms of radiotherapy, chemotherapy and hormonal therapy are now available. This interdisciplinary approach is reflected in the broad scope of this volume, which aims to provide an overview of current treatment strategies for bladder and prostate cancer. The first part of the book discusses the optimization of radiation techniques like 3 D planning or IMRT and focuses on definitive radiotherapy with or without adjuvant or neoadjuvant hormonal manipulation. The quality of life after therapy is another important issue. Further chapters deal with radical cystectomy and organ preservation by radio-chemotherapy as well as the treatment of T1G3 cancer. In the last part, the emphasis lies on brachytherapy, which has become increasingly important for the treatment of prostate cancer. This book will be of great value to urologists and radiation oncologists as well as to all others involved in the care of patients with urologic cancer.
Controversies in Uro-Oncology: 5th International Symposium on Special Aspects of Radiotherapy, Berlin, May 2000
Edited by: T. Wiegel, W. Hinkelbein, K. Miller, R. Heicappell
https://doi.org/10.1159/isbn.978-3-318-00695-7
ISBN (print): 978-3-8055-7217-0
ISBN (electronic): 978-3-318-00695-7
Publisher: S.Karger AG
Published: 2002
Download citation file:
Digital Version
Pay-Per-View Access
$219.00
Print Version
Controversies in Uro-Oncology
$219.00
Table of Contents
-
1 - 9: Planning Target Volume and Dose Prescription in Definitive Radiotherapy for Prostate Cancer with Favourable Prognostic FactorsByS. Wachter;S. WachterDepartment of Radiotherapy and Radiobiology, University Hospital, Vienna, AustriaSearch for other works by this author on:N. Gerstner;N. GerstnerDepartment of Radiotherapy and Radiobiology, University Hospital, Vienna, AustriaSearch for other works by this author on:U. Mock;U. MockDepartment of Radiotherapy and Radiobiology, University Hospital, Vienna, AustriaSearch for other works by this author on:R. PötterR. PötterDepartment of Radiotherapy and Radiobiology, University Hospital, Vienna, AustriaSearch for other works by this author on:
-
10 - 15: Dose Escalation for Prostate Cancer: Which Dose for Which Person?ByH.M. SandlerH.M. SandlerDepartment of Radiation Oncology, The University of Michigan, Ann Arbor, Mich., USASearch for other works by this author on:
-
16 - 24: Planning Target Volume Definition in Dose-Escalation StudiesByD. Vordermark;D. VordermarkKlinik und Poliklinik für Strahlentherapie, Wü rzburg, GermanySearch for other works by this author on:M. FlentjeM. FlentjeKlinik und Poliklinik für Strahlentherapie, Wü rzburg, GermanySearch for other works by this author on:
-
25 - 34: Inverse Planning and Intensity-Modulated Radiotherapy in Patients with Prostate CancerByJ. Debus;J. DebusRadiologische Klinik, Universitätsklinikum Heidelberg und Deutsches Krebsforschungszentrum (dkfz), Heidelberg, DeutschlandSearch for other works by this author on:D. Zierhut;D. ZierhutRadiologische Klinik, Universitätsklinikum Heidelberg und Deutsches Krebsforschungszentrum (dkfz), Heidelberg, DeutschlandSearch for other works by this author on:B. Didinger;B. DidingerRadiologische Klinik, Universitätsklinikum Heidelberg und Deutsches Krebsforschungszentrum (dkfz), Heidelberg, DeutschlandSearch for other works by this author on:W. Schlegel;W. SchlegelRadiologische Klinik, Universitätsklinikum Heidelberg und Deutsches Krebsforschungszentrum (dkfz), Heidelberg, DeutschlandSearch for other works by this author on:M. WannenmacherM. WannenmacherRadiologische Klinik, Universitätsklinikum Heidelberg und Deutsches Krebsforschungszentrum (dkfz), Heidelberg, DeutschlandSearch for other works by this author on:
-
35 - 42: Radiotherapy after Radical Prostatectomy in Patients with Prostate-Specific Antigen ElevationByT. Wiegel;T. WiegelDepartment of Radiotherapy, University Hospital Benjamin Franklin, Freie Universität, Berlin, GermanySearch for other works by this author on:W. HinkelbeinW. HinkelbeinDepartment of Radiotherapy, University Hospital Benjamin Franklin, Freie Universität, Berlin, GermanySearch for other works by this author on:
-
43 - 48: Is Radiotherapy of Pelvic Lymph Nodes Successful in Prostate Cancer?
-
49 - 65: Hormone Therapy in Advanced Prostate CancerByT.H. Forster;T.H. ForsterUrologic Clinic, University of Basel, SwitzerlandSearch for other works by this author on:F. Stoffel;F. StoffelUrologic Clinic, University of Basel, SwitzerlandSearch for other works by this author on:T.C. GasserT.C. GasserUrologic Clinic, University of Basel, SwitzerlandSearch for other works by this author on:
-
66 - 71: Intermittent Androgen Ablation as a Treatment for Prostate CancerByJ.M. WolffJ.M. WolffDepartment of Urology, University of Rostock, GermanySearch for other works by this author on:
-
72 - 80: Controversies in Chemotherapy of Prostate CancerByR. HeicappellR. HeicappellDepartment of Urology, Universitätsklinikum Benjamin Franklin, Freie Universität, Berlin, GermanySearch for other works by this author on:
-
81 - 86: Adjuvant Hormone Therapy in Locally Advanced and Localized Prostate Cancer: Three EORTC TrialsByM. Bolla;M. BollaEORTC Radiotherapy and Genito-Urinary Cooperative Groups, EORTC Data Center, Brussels, BelgiumSearch for other works by this author on:T.M. de Reijke;T.M. de ReijkeEORTC Radiotherapy and Genito-Urinary Cooperative Groups, EORTC Data Center, Brussels, BelgiumSearch for other works by this author on:A. Zurlo;A. ZurloEORTC Radiotherapy and Genito-Urinary Cooperative Groups, EORTC Data Center, Brussels, BelgiumSearch for other works by this author on:L. ColletteL. ColletteEORTC Radiotherapy and Genito-Urinary Cooperative Groups, EORTC Data Center, Brussels, BelgiumSearch for other works by this author on:
-
87 - 98: Neoadjuvant Androgen Suppression and External Beam Radiation TherapyByA.L. Zietman;A.L. ZietmanDepartment of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Mass., USASearch for other works by this author on:C.T. SmithC.T. SmithDepartment of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Mass., USASearch for other works by this author on:
-
99 - 105: Quality of Life following Radical ProstatectomyByR. Kirschner-Hermanns;R. Kirschner-HermannsUrological Clinic, University Clinic, Rheinisch-Westfälische Technical University, Aachen, GermanySearch for other works by this author on:G. JakseG. JakseUrological Clinic, University Clinic, Rheinisch-Westfälische Technical University, Aachen, GermanySearch for other works by this author on:
-
106 - 117: Outcome of Patients Undergoing Radical Cystectomy for Invasive Bladder CancerByJ.E. GschwendJ.E. GschwendDepartment of Urology, University of Ulm, GermanySearch for other works by this author on:
-
118 - 130: Invasive Bladder Cancer: Organ Preservation by RadiochemotherapyByG.G. Grabenbauer;G.G. GrabenbaueraDepartments of Radiation Oncology andSearch for other works by this author on:J. Dunst;J. Dunstd Department of Radiation Oncology, University of Halle, GermanySearch for other works by this author on:T. Papadopoulos;T. Papadopoulosc Institute of Pathology, University of Erlangen;Search for other works by this author on:R. SauerR. SaueraDepartments of Radiation Oncology andSearch for other works by this author on:
-
131 - 146: Radiation, Chemotherapy and Transurethral Surgery: An Organ-Sparing Alternative to the Radical CystectomyByA.L. ZietmanA.L. ZietmanMassachusetts General Hospital, Harvard Medical School, Boston, Mass., USASearch for other works by this author on:
-
147 - 150: T1G3 Bladder Cancer - The Case for TUR and BCGByK. MillerK. MillerDepartment of Urology, University Medical Center Benjamin Franklin, Berlin, GermanySearch for other works by this author on:
-
151 - 158: Radiochemotherapy for T1G3 Bladder CancerByJ. Dunst;J. DunstaDepartments of Radiotherapy, Universities of Halle andSearch for other works by this author on:A. Diestelhorst;A. DiestelhorstaDepartments of Radiotherapy, Universities of Halle andSearch for other works by this author on:R. SauerR. Sauerb Erlangen and Departments of Urology,Search for other works by this author on:
-
159 - 165: The Technique of 125I Permanent ImplantsByU. Maurer;U. MaurerUniversitätsklinikum der RWTH Aachen, Klinik für Strahlentherapie, Aachen, DeutschlandSearch for other works by this author on:M.J. EbleM.J. EbleUniversitätsklinikum der RWTH Aachen, Klinik für Strahlentherapie, Aachen, DeutschlandSearch for other works by this author on:
-
166 - 170: Interstitial Brachytherapy with Permanent Seed Implants in Early Prostate CancerByU. Maurer;U. MaureraKliniken für Strahlentherapie, Universitätsklinikum der RWTH, Aachen undSearch for other works by this author on:T. Wiegel;T. Wiegelb Universitätsklinikum Benjamin Franklin, Berlin, DeutschlandSearch for other works by this author on:W. Hinkelbein;W. Hinkelbeinb Universitätsklinikum Benjamin Franklin, Berlin, DeutschlandSearch for other works by this author on:M.J. EbleM.J. EbleaKliniken für Strahlentherapie, Universitätsklinikum der RWTH, Aachen undSearch for other works by this author on:
-
171 - 176: Interstitial Hyperthermia Using Thermoseeds in Combination with Conformal Radiotherapy for Localized Prostate CancerByD. Böhmer;D. Böhmerb Radiation Therapy, Charité Hospital, Humboldt University, Berlin, GermanySearch for other works by this author on:V. Budach;V. Budachb Radiation Therapy, Charité Hospital, Humboldt University, Berlin, GermanySearch for other works by this author on:S.A. LoeningS.A. LoeningaDepartments of Urology andSearch for other works by this author on:
-
177 - 182: High-Dose Rate Brachytherapy - The Charité ExperienceByS. Deger;S. Degerb Urology, Charité, Humboldt University of Berlin, GermanySearch for other works by this author on:D. Schnorr;D. Schnorrb Urology, Charité, Humboldt University of Berlin, GermanySearch for other works by this author on:S.A. Loening;S.A. Loeningb Urology, Charité, Humboldt University of Berlin, GermanySearch for other works by this author on:V. BudachV. BudachaDepartments of Radiotherapy andSearch for other works by this author on:
-
183 - 190: Anatomy-Related and Transrectal Sonography-Guided Interstitial High-Dose Rate Brachytherapy Combined with Elective Irradiation of the Pelvic Lymphatics for Localized Prostate Cancer: The Kiel ExperienceByR. Galalae;R. GalalaeInterdisciplinary Brachytherapy Center, Christian Albrechts University, Kiel, GermanySearch for other works by this author on:G. Kovács;G. KovácsInterdisciplinary Brachytherapy Center, Christian Albrechts University, Kiel, GermanySearch for other works by this author on:T. Loch;T. LochInterdisciplinary Brachytherapy Center, Christian Albrechts University, Kiel, GermanySearch for other works by this author on:H. Bertermann;H. BertermannInterdisciplinary Brachytherapy Center, Christian Albrechts University, Kiel, GermanySearch for other works by this author on:P. Kohr;P. KohrInterdisciplinary Brachytherapy Center, Christian Albrechts University, Kiel, GermanySearch for other works by this author on:A. Oldörp;A. OldörpInterdisciplinary Brachytherapy Center, Christian Albrechts University, Kiel, GermanySearch for other works by this author on:B. KimmigB. KimmigInterdisciplinary Brachytherapy Center, Christian Albrechts University, Kiel, GermanySearch for other works by this author on:
